NO941073L - Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater - Google Patents
Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivaterInfo
- Publication number
- NO941073L NO941073L NO941073A NO941073A NO941073L NO 941073 L NO941073 L NO 941073L NO 941073 A NO941073 A NO 941073A NO 941073 A NO941073 A NO 941073A NO 941073 L NO941073 L NO 941073L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- stands
- branched alkyl
- hydrogen
- straight chain
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title abstract 3
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 title abstract 2
- GXBRYTMUEZNYJT-UHFFFAOYSA-N 2-anilinoacetamide Chemical compound NC(=O)CNC1=CC=CC=C1 GXBRYTMUEZNYJT-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 11
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4309968A DE4309968A1 (de) | 1993-03-26 | 1993-03-26 | Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941073D0 NO941073D0 (no) | 1994-03-24 |
| NO941073L true NO941073L (no) | 1994-09-27 |
Family
ID=6484001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941073A NO941073L (no) | 1993-03-26 | 1994-03-24 | Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0622358A1 (cs) |
| JP (1) | JPH06329637A (cs) |
| KR (1) | KR940021532A (cs) |
| CN (1) | CN1102645A (cs) |
| AU (1) | AU5788694A (cs) |
| CA (1) | CA2119669A1 (cs) |
| CZ (1) | CZ71094A3 (cs) |
| DE (1) | DE4309968A1 (cs) |
| FI (1) | FI941380A7 (cs) |
| HU (1) | HUT68514A (cs) |
| IL (1) | IL109093A0 (cs) |
| NO (1) | NO941073L (cs) |
| NZ (1) | NZ260163A (cs) |
| SK (1) | SK35094A3 (cs) |
| ZA (1) | ZA942119B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2219944A1 (en) * | 1995-05-19 | 1996-11-21 | Miho Kobayashi | 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors |
| DE19613550A1 (de) * | 1996-04-04 | 1997-10-09 | Bayer Ag | Neue Pyrimido[1,2-a]indole |
| EP0802192A1 (de) * | 1996-04-17 | 1997-10-22 | Bayer Ag | Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung |
| DE19619950A1 (de) | 1996-04-17 | 1997-10-23 | Bayer Ag | Heterocyclisch-substituierte Phenylglycinolamide |
| DE19615265A1 (de) * | 1996-04-18 | 1997-12-04 | Bayer Ag | Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole |
| CN1304000C (zh) * | 1998-12-23 | 2007-03-14 | 诺瓦提斯公司 | 缬沙坦在制备用于治疗肺癌的药物中的用途 |
| EP1013273A1 (en) * | 1998-12-23 | 2000-06-28 | Novartis AG | Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05504969A (ja) * | 1990-02-13 | 1993-07-29 | メルク・エンド・カムパニー・インコーポレーテツド | 置換ベンジル要素を含有するアンギオテンシン2アンタゴニスト類 |
| WO1991012002A1 (en) * | 1990-02-13 | 1991-08-22 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating a substituted benzyl element |
| DE4036645A1 (de) * | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
| DE4200954A1 (de) * | 1991-04-26 | 1992-10-29 | Bayer Ag | Heterocyclisch substituierte phenylessigsaeurederivate |
| DE4208051A1 (de) * | 1992-03-13 | 1993-09-16 | Bayer Ag | Substituierte phenylessigsaeureamide |
-
1993
- 1993-03-26 DE DE4309968A patent/DE4309968A1/de not_active Withdrawn
-
1994
- 1994-03-14 EP EP94103881A patent/EP0622358A1/de not_active Withdrawn
- 1994-03-17 AU AU57886/94A patent/AU5788694A/en not_active Abandoned
- 1994-03-22 JP JP6073763A patent/JPH06329637A/ja not_active Ceased
- 1994-03-23 CA CA002119669A patent/CA2119669A1/en not_active Abandoned
- 1994-03-23 NZ NZ260163A patent/NZ260163A/en unknown
- 1994-03-23 IL IL10909394A patent/IL109093A0/xx unknown
- 1994-03-24 NO NO941073A patent/NO941073L/no unknown
- 1994-03-24 FI FI941380A patent/FI941380A7/fi not_active Application Discontinuation
- 1994-03-25 CZ CZ94710A patent/CZ71094A3/cs unknown
- 1994-03-25 ZA ZA942119A patent/ZA942119B/xx unknown
- 1994-03-25 KR KR1019940006036A patent/KR940021532A/ko not_active Withdrawn
- 1994-03-25 HU HU9400865A patent/HUT68514A/hu unknown
- 1994-03-25 SK SK350-94A patent/SK35094A3/sk unknown
- 1994-03-26 CN CN94103443A patent/CN1102645A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1102645A (zh) | 1995-05-17 |
| KR940021532A (ko) | 1994-10-19 |
| AU5788694A (en) | 1994-09-29 |
| NO941073D0 (no) | 1994-03-24 |
| DE4309968A1 (de) | 1994-09-29 |
| IL109093A0 (en) | 1994-06-24 |
| ZA942119B (en) | 1994-11-07 |
| JPH06329637A (ja) | 1994-11-29 |
| CZ71094A3 (en) | 1994-10-19 |
| CA2119669A1 (en) | 1994-09-27 |
| SK35094A3 (en) | 1995-10-11 |
| HUT68514A (en) | 1995-06-28 |
| FI941380A0 (fi) | 1994-03-24 |
| FI941380A7 (fi) | 1994-09-27 |
| NZ260163A (en) | 1996-02-27 |
| HU9400865D0 (en) | 1994-06-28 |
| EP0622358A1 (de) | 1994-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69722027D1 (de) | Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung | |
| AR050917A1 (es) | Compuestos basados en 2-amido-tiazol que presentan actividad inhibidora de enzimas que utilizan atp, y composiciones y usos de los mismos | |
| LV12712A (lv) | Inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodekstrin and method | |
| NO20074071L (no) | Hydrazinometyl, hydrozonometyl og 5-leddete heterocykliske forbindelser som virker som MTOR inhibitorer og anvendelse derav som anti-cancer midler | |
| ATE128972T1 (de) | Isoxazolderivate, verfahren zu deren herstellung and deren anwendung als herbizide. | |
| NO941770L (no) | Substituert mono- og bipyridylmetylpyridon | |
| NO931433D0 (no) | 4,1-benzoksazepinderivater og deres anvendelse | |
| NO975987L (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
| DK1113011T3 (da) | Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer | |
| FI964463A0 (fi) | Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina | |
| ES2126075T3 (es) | Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa. | |
| NO941073L (no) | Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater | |
| WO2003080596A3 (en) | Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides | |
| EP0259835A3 (en) | Pyridazinone derivatives | |
| NO941516L (no) | 3-kinolylsubstituerte dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse | |
| DE69425266D1 (de) | Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung | |
| MX2007004482A (es) | Derivados de piridina y la preparacion y el uso terapeutico de los mismos. | |
| NO20073213L (no) | Fremgangsmate for fremstilling av tiofenglykosidderivater | |
| PH27293A (en) | Aryloxy arlthip heteroaryloxy heteroarylthio-alkenylene derivatives of amine and a method of use thereof | |
| TW330147B (en) | Halogenobenzimidazoles, their preparation processes and their use | |
| NO924516L (no) | Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler | |
| HUT48201A (en) | Herbicide comprising anilide derivatives and process for producing such compounds | |
| BR9812928B1 (pt) | derivados de 3-oxo-(2h)-1,2,4-triazina, compostos, processo de preparaÇço de compostos quÍmicos, e, composiÇço farmacÊutica. | |
| NO941519L (no) | 2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidler | |
| ATE239707T1 (de) | 2-phenylpyridine-derivate und verfahren zu deren herstellung |